Skip to content
zameds

Cephalexin (Aspen-cephalexin 125p, Aspen-cephalexin 250p, Aspen-cephalexin, Keflex, Keflex P, Lenocef)

Cephalexin

Pharmacare limited û woodmead

Every registration of this product has been cancelled.

Registration

Applicant
Pharmacare limited û woodmead
Registrations
11

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Aspen-cephalexin 125p

EACH 5 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 125 mg CEPHALEXIN

Not listed29053429/20.1.1/0534CancelledNot determinedNone
Aspen-cephalexin 250p

EACH 5 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 250 mg CEPHALEXIN

Not listed29059529/20.1.1/0595CancelledNot determinedNone
Aspen-cephalexin 250

EACH CAPSULE CONTAINS CEPHALEXIN 250 mg

25030012830/20.1.1/0128CancelledNot determinedNone
Keflex 250

EACH CAPSULE CONTAINS CEPHALEXIN 250 mg

250B0092B/20.1.1/92CancelledNot determinedNone
Keflex 125 p

EACH 5 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 125 mg CEPHALEXIN

125C0028C/20.1.1/28CancelledNot determinedNone
Keflex 250 p

EACH 5 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 250 mg CEPHALEXIN

250C0029C/20.1.1/29CancelledNot determinedNone
Keflex 500

EACH TABLET CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 500 mg CEPHALEXIN

500C0220C/20.1.1/220CancelledNot determinedNone
Lenocef - 250

EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 250 mg

- 250N0128N/20.1.1/128CancelledNot determinedNone
Lenocef-500

EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 500 mg CEPHALEXIN

500N0129N/20.1.1/0129CancelledNot determinedNone
Lenocef - 125 suspension

EACH 5 ml RECONSTITUTED SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 125 mg CEPHALEXIN

- 125SuspensionN0134N/20.1.1/134CancelledNot determinedNone
Lenocef-250 suspension

EACH 5 ml RECONSTITUTED SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 250 mg CEPHALEXIN

250SuspensionN0135N/20.1.1/135CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C16H17N3O4S347.40 g/mol

(6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Drag to rotate. Structure from PubChem CID 27447.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles